Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Editorial
Guest Editorial
Letter to Editor
Original Article
Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Editorial
Guest Editorial
Letter to Editor
Original Article
Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Editorial
Guest Editorial
Letter to Editor
Original Article
Review Article
View/Download PDF

Translate this page into:

Review Article
3 (
2
); 100-105
doi:
10.25259/ABMH_45_2025

Neurodevelopmental Blueprint of Gender: From Embryo to Identity -Bridging Biology and Beyond

Department of Psychiatry, Gauhati Medical College and Hospital, Gauhati, Assam, India.

*Corresponding author: Dr Dipanjana Hazra, MBBS, Post graduate trainee second year, Department of psychiatry, Gauhati Medical College and Hospital, Assam, India. dipanjanah@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Medhi D, Hazra D. Neurodevelopmental Blueprint of Gender: From Embryo to Identity - Bridging Biology and Beyond. Acad Bull Ment Health. 2025;3:100-5. doi: 10.25259/ABMH_45_2025

Abstract

Gender Identity unfolds as a layered narrative, shaped by genetic signals, prenatal hormones, brain circuitry, and environmental encounters. This article invites readers to go through the developmental journey from embryo to identity -bridging primary research findings to ethical insight. It tells the story of how nature, environment, and identity work together, crafting the rich diversity of human gender beyond barriers. While this review primarily explores the biological blueprint of gender identity established during fetal development, it recognizes that postnatal psychosocial and cultural influences continue to shape identity formation until its stabilization in early childhood (around 2.5 -3 years)

Keywords

Endocrine disruptors
Gender identity
Neurodevelopment
Prenatal hormones

INTRODUCTION

In recent years, terminology related to gender dysphoria (GD) has undergone significant changes; for example, previously labeled as “gender identity disorder”, in Diagnostic and Statistical Manual of Mental Disorders (DSM-5) known as “gender dysphoria”, and in ICD-11 as “gender incongruence”. “Gender incongruence” is considered ‘a sustained and marked mismatch between an individual’s experienced gender and sex assigned at birth.’ Importantly, gender -variant behaviors or preferences alone are not sufficient for a diagnosis in this category.[1] The term ‘GD’ is currently the predominant term, describing ‘the distress that occurs when an individual’s experienced or expressed gender does not correspond with their assigned sex at birth’.[2] Despite this, terminology continues to be a source of confusion. The emergence of additional concepts such as gender fluidity,asexuality, transgender, cisgender male, and female has further complicated it. Moreover, evolving regulations surrounding gender -affirming surgeries and hormone therapies have brought greater clinical attention to the subject, underscoring the need for a thorough scientific understanding of gender identity. The evolving nosology of gender identity from disorder-based to incongruence-based reflects a paradigm shift from pathologizing to understanding. This change underscores the need to explore biological and developmental foundations that may explain gender diversity without attributing to pathology – a focus of this review.

Epidemiology

According to DSM-5 estimates, the prevalence of GD in adults assigned male at birth is approximately 0.005-0.014%, whereas in adults assigned female at birth it is around 0.002-0.003%.[3] The true prevalence remains uncertain and appears to vary across regions, influenced by cultural factors and differing diagnostic criteria internationally.[3,4] In recent years, the demand for gender-affirming care has risen by about 18% each year (95% 1.08- 1.30), with presentations occurring progressively at younger ages.[3] Multiple explanations have been proposed for this trend, including a genuine rise in prevalence, greater willingness to seek professional help, increasing societal awareness, extensive media coverage, internet-based information and peer support, lesbian, gay, bisexual, transgender and queer (LGBTQ) advocacy, reduction in stigma, improved recognition among healthcare providers, and advances in scientific knowledge regarding GD.[5] These epidemiological trends reinforce that gender identity is an evolving construct influenced not only by social awareness but also by the biological foundations laid early in life.

Biology of gender

Genetic and chromosomal factors

more than just XX or XY. Sexual differentiation is a complex and multifactorial process that involves not only sex chromosomes (allosomes) but also many genes located on autosomes.[6] It refers to the developmental events that guide the formation of testes or ovaries from an initially “bipotential” or undifferentiated gonadal structure.[7] This process begins around the 7th week of embryonic life. At first, both sexes share similar genital precursors, but transcription factors act as critical switches that direct gonadal development. Initially, two pairs of ducts (mesonephric and paramesonephric) are present; depending on genetic and hormonal influences, one set proliferates while the other regresses.[6]

XY pathway and testicular development

In those carrying an XY chromosomal set, expression of the ‘SRY gene’ drives the transformation of primitive gonadal tissues into testes. These testes form Leydig and Sertoli cells.[6]

Leydig cells produce testosterone, which binds to androgen receptors and stabilizes the mesonephric (Wolffian) duct, driving male reproductive development.[8] Expression of ‘steroidogenic factor’ marks one of the earliest events in the gonadal cell differentiation.[9] Sertoli cells, under the influence of SRY, SOX9, and steroidogenic factor 1 (Sf1), release anti-Müllerian hormone (AMH), leading to the regression of the paramesonephric (Müllerian) ducts, thereby preventing female reproductive structures from forming.[10,11]

XX pathway and ovarian differentiation

Conversely, in XX embryos, the lack of SRY, testosterone, and AMH leads to a distinct development trajectory. The paramesonephric ducts develop into female reproductive structures, while the mesonephric ducts degenerate in the absence of testosterone.[6] Genes such as Wnt4 (Wingless-related integration site gene) and Rspo1 (R-spondin 1)—key players in the Wnt signaling pathway—become more active, suppressing SRY-box transcription factor 9 (SOX9) and promoting ovarian development.[12] Mutations in Rspo1 can disrupt this balance, sometimes leading to conditions like XX testicular differences in sexual development (DSD).[13]

However, even receptor level or hormonal resistance can show variations in sexual development as seen in Androgen Insensitivity Syndrome.

Disorder of sexual differentiation (androgen insensitivity syndrome )

DSDs represent a spectrum of variations in sex development.[6] Androgen insensitivity syndrome (AIS) is one such condition, caused by mutations or deletions in the gene regulating androgen receptor (AR) activity.[14,15] In AIS, although the individual has XY chromosomes, tissues cannot respond fully to androgens. This may result in a female phenotype, ambiguous genitalia, or a spectrum of presentations depending on the extent of receptor sensitivity.[6]

Interestingly, genetic studies also suggest associations between certain gene variations and gender diversity. For example, studies have shown that women with non cis gender identities tend to have longer cytosine–adenine– guanine (CAG) repeats in the gene encoding the androgen receptor compared to cis gender women.[16] Likewise, a specific mutated variant of the CYP17 gene, which regulates sex hormone production, was observed more commonly in men with non cis gender identity.[17] While no single “ gene” has been pinpointed as definitive, these observations suggest the role of complex genetic and hormonal interactions in shaping gender identity.

Thus, biological sex differentiation is not determined solely by chromosomes (XX or XY). Instead, it involves an intricate interplay of genes, hormones, and developmental pathways that begin in early fetal life. This complexity underscores the natural diversity in human sex and gender development, moving beyond a simplistic binary model.

Endocrine disruptors

The United States Environmental Protection Agency (EPA) defines an endocrine-disrupting compound (EDC) as “any substance that interferes with the synthesis, secretion, transport, binding, or metabolism of natural hormones that regulate homeostasis, reproduction, growth, development, and behavior”.[18] These compounds are diverse[19] and broadly categorized into two groups.[20]

  1. Naturally occurring EDCs – such as phytoestrogens.

  2. Synthetic EDCs – including chemicals and secondary products generated through industrial processes, plastics, plasticizers, pesticides, fungicides, and certain pharmaceutical agents.[20,21]

While much of the evidence regarding the effects of EDCs comes from animal studies, human data remain limited. Compounds such as dichlorodiphenyltrichloroethane, bisphenol A (BPA), and di (2-ethylhexyl) phthalate (DEHP) have been shown to cause epigenetic modifications, including histone changes, DNA methylation, and altered expression of non-coding RNAs.[22-24] These findings raise the possibility that environmental exposures may influence brain sexual differentiation, particularly when exposure occurs during sensitive developmental stages.[25] For example, pregnant mice exposed to BPA at doses below current human safety limits produced offspring with long-lasting alterations in sex-related behaviors.[26,27] Moreover, some of these effects appear to be transgenerational, affecting subsequent generations even without direct exposure, suggesting an epigenetic mode of inheritance.[28-31] At present, these observations remain hypotheses, and no definitive conclusions can be drawn from the available evidence.

These findings suggest that environmental exposures may add another layer of complexity to the biological foundations of gender identity, complementing genetic and hormonal pathways.

Neuroanatomical correlates

Research on gender identity has explored several domains, including structural neuroanatomy, functional neuroimaging, genetics, and prenatal hormone exposure.[3] A common limitation across studies is the relatively small sample sizes and the assumption that gender-diverse individuals form a homogeneous group, when in fact they represent multiple subgroups.[3,32] An example of a few such anatomical sites has been mentioned below-

Bed nucleus of the stria terminalis (BSTc): One of the earliest and most consistently studied regions is the Bed Nucleus of the Stria Terminalis (BSTc). Differences are noted between cisgender males, cisgender females, and transgender women in ‘the bed nucleus of the stria terminalis (BSTc)’. In trans women,both ‘BSTc’ size and neuronal count resemble those of typical females.[33] ‘Somatostatin-expressing neurons’ in the ‘BSTc’ follow a similar pattern: trans women and typical females have comparable numbers, while typical males have nearly twice the count compared to females. Trans men show counts similar to typical males. These findings appear independent of hormone therapy.[34]

Interstitial nucleus of the anterior hypothalamus (INAH3 and INAH4): Building upon these early observations, subsequent research examined other hypothalamic nuclei -particularly the Interstitial nuclei of the anterior hypothalamus. These nuclei demonstrate sexual dimorphism. ‘INAH3’ volume and neuron count are greater in cisgender men than in cisgender women. In transgender women, values align more closely with cisgender women, while transgender men resemble cisgender men—even after discontinuation of testosterone therapy for several years, suggesting the effect is not merely hormonal.[32] Similarly, the INAH4 shape differs by sex: elongated in cisgender and transgender men but spherical in cisgender women.[32]

Kisspeptin system: Additional hypothalamic systems, such as the kisspeptin network, provide further insight into neuroendocrine integration in gender identity formation. Postmortem studies have shown that kisspeptin-expressing neurons in the infundibular nucleus were comparable between cisgender men and transgender men, suggesting that brain sex characteristics and body sex can develop along different trajectories.[35]

In functional neuroimaging: All the above-mentioned studies present static observations, whereas functional neuroimaging studies extend this understanding by exploring how these neural circuits operate dynamically in living individuals.Resting-state fMRI studies in adolescents with GD have shown connectivity patterns that diverge from their birth-assigned sex and more closely resemble those typical of their experienced gender. Interestingly, such differences are not observed in prepubertal children, implying that these brain connectivity patterns may emerge during puberty.[36,37]

Together, structural and functional neuroimaging findings suggest that gender identity is rooted in neurodevelopmental organization rather than purely environmental learning. This neurobiological evidence is complemented by genetic and familial studies that further illuminate inherited influences.

Genetics study and twin evidence

The role of genetics in gender identity has been examined through family and twin studies.[3] Early reports described parent-child and sibling pairs where more than one family member identified with GD, suggesting a possible genetic influence.[38] However, larger studies indicate that while familial occurrence exists, it is relatively rare.[39] Twin studies provide stronger evidence: concordance rates for GD are higher in monozygotic twins compared to dizygotic twins, consistent with a genetic contribution.[3,40,41]

Cytogenetic research has produced mixed results. A large study in Spain reported a five-fold increase in chromosomal variations among transgender women and men versus the general population, while another study in adolescents found no such increase.[42-44] Taken together, genetic data support biological predisposition but indicate that genes interact with environmental and hormonal factors in a complex way.

Prenatal hormone exposure: Prenatal androgen exposure has been suggested as one factor influencing later gender-related expression.[3] One commonly studied proxy for such exposure is the 2D:4D finger length ratio, considered an indirect marker of prenatal androgen levels.[45] One study examined 96 individuals recorded as male at birth and 51 recorded as female at birth who had ‘GD ‘, and compared them with 90 male-at-birth and 112 female-at-birth controls without the condition.The research also included a comparison of 67 boys and 34 girls with ‘GD’ against 74 boys and 72 girls without the condition, highlighting specific differences between the groups. Among assigned males, both in adult and child groups, analysis of the 2D:4D ratio revealed no meaningful difference between the GD and control groups. However, among assigned females, adults with GD showed a more “masculinized” digit ratio compared to controls.[46] This has been interpreted as suggestive of differing prenatal hormone exposure in this group. Other investigations have speculated that reduced prenatal testosterone may be involved in the origin of ‘GD’ in assigned females, though similar findings have not been consistently demonstrated in birth-assigned males.[47] While not definitive, these results support the possibility that variations in prenatal androgen exposure may have an impact on the development of gender identity.[3] Although biological determinants lay the foundation, the final consolidation of gender identity is also shaped by early life experiences, social affirmation, and cultural context.

Psychosocial perspectives: Psychosocial influences on gender identity development involve a combination of parental responses, cognitive development, associated psychosocial conditions, and underlying psychodynamic factors. Parents often react to early cross-gender behavior with neutrality or mild encouragement, perceiving it as a harmless phase until it becomes persistent or socially concerning.[48] Young children’s incomplete grasp of gender constancy – mistaking gender for outward expressions like clothing or activities – may contribute to ongoing confusion about gender roles.[49,50] Emotional or behavioral problems, including anxiety, and family stress. Or autism spectrum traits can intensify gender related behavior by fostering rigid thinking or obsessive interests.[51,52] From a psychodynamic perspective, unresolved parental conflicts or traumatic experiences can unconsciously influence a child’s gender identity. This signifies that gender identity evolves through a complex interaction of social, cognitive, emotional, and familial processes.[53]

Disclaimer

It is important to clarify that the exploration of biological factors such as prenatal hormone exposure and endocrine disruptors in this article is not intended to pathologize gender diversity; rather, it aims to contribute to a detailed scientific discussion of the complex nature of gender identity.

CONCLUSION

This review discusses diverse factors that can influence gender identity, but no one can be concluded as the determining factor. Rather, a detailed discussion may throw some light on the hidden truth of human sex development, both brain sex as well as body sex. As this is an era of advanced technology, we can hope that in the near future,further mysteries will be unwrapped and the development of gender can be understood in a better way. Understanding this continuum – from biological predisposition to social realization invites a more integrated model of gender identity that respects both science and lived experience. Gender is not a binary concept anymore. So recognizing and respecting the non-binary spectrum of gender with dignity is not just a scientific or ethical imperative- it is the foundation for building a more inclusive society where every individual can live with authenticity, acceptance, and equal opportunity.

Authors’ contributions:

DM: Study conception, design and review; DH: Manuscript preparation and review.

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

Patient's consent not required as there are no patients in this study.

Conflicts of interest:

Dr. Deepanjali Medhi is on the Editorial Board of the Journal.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. . International Statistical Classification of Diseases and Related Health Problems, 11th Revision (ICD-11) 2018 (adopted 2019). Category HA60-HA6Z (Chapter 17: Conditions related to sexual health). Available from: https://icd.who.int/browse11/lm/en#/http://id.who.int/icd/entity/411470068 [Last accessed 2025 Sept 10]
    [Google Scholar]
  2. . Diagnostic and Statistical Manual of Mental Disorders. . (5th Ed). Arlington (VA): American Psychiatric Publishing; Availabe from: https://www.psychiatry.org/psychiatrists/practice/dsm [Last accessed 2025 Sept 10]
    [Google Scholar]
  3. , , , , . Gender Dysphoria in Children and Adolescents: An Overview. Hormones (Athens). 2020;19:267-76.
    [CrossRef] [PubMed] [Google Scholar]
  4. , . Gender dysphoria. Aust Fam Physician. 2015;44:792-6.
    [Google Scholar]
  5. , . Individuals Seeking Gender Reassignment: Marked Increase in Demand for Services. BJPsych Bull. 2018;42:206-10.
    [CrossRef] [PubMed] [Google Scholar]
  6. , . Gender Dysphoria: A Review Investigating the Relationship Between Genetic Influences and Brain Development. Adolesc Health Med Ther. 2020;11:89-99.
    [CrossRef] [PubMed] [Google Scholar]
  7. . Sexual Differentiation. . Encyclopaedia Britannica [Internet]. Chicago: Encyclopaedia Britannica Inc.; Available from: https://www.britannica.com/science/sexual-differentiation [Last accessed 2020 Jul 9]
    [Google Scholar]
  8. , , , , . Changes in Gene Expression During Wolffian Duct Development. Horm Res. 2006;65:200-9.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , . A Cell-Specific Nuclear Receptor is Essential for Adrenal and Gonadal Development and Sexual Differentiation. Cell. 1994;77:481-90.
    [CrossRef] [PubMed] [Google Scholar]
  10. , . Sex Determination Involves Synergistic Action of SRY and SF1 on a Specific Sox9 Enhancer. Nature. 2008;453:930-4.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , . Genetics of Gonadal Determination. Ann Endocrinol (Paris). 2014;75:32-9.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , . The Genetics of Disorders of Sex Development in Humans. Sex Dev. 2014;8:262-72.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , , , , et al. R-spondin1 is Essential in Sex Determination, Skin Differentiation and Malignancy. Nat Genet. 2006;38:1304-9.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , . Complete Androgen Insensitivity Syndrome With a Large Gonadal Serous Papillary Cystadenofibroma. J Hum Reprod Sci. 2014;7:148-50.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , , . Androgen Insensitivity Syndrome. Lancet. 2012;380:1419-28.
    [CrossRef] [PubMed] [Google Scholar]
  16. , , , , , . Polymorphic Cytosine-Adenine-Guanine Repeat Length of Androgen Receptor Gene and Gender Incongruence in Trans Women: A Systematic Review and Meta-Analysis of Case-Control Studies. J Sex Med. 2020;17:543-50.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , , et al. The CYP17 MspA1 Polymorphism and Gender Dysphoria. J Sex Med. 2015;12:1329-33.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , , , et al. Research Needs for the Assessment of Health and Environmental Effects of Endocrine Disruptors: A Report of the U.S. EPA-Sponsored Workshop. Environ Health Perspect. 1996;104:715-40.
    [CrossRef] [PubMed] [Google Scholar]
  19. . Endocrine Disruptors as Obesogens. Mol Cell Endocrinol. 2009;304:19-29.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , , , , et al. Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocr Rev. 2009;30:293-342.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , . A Review on Endocrine Disruptors and Their Possible Impacts on Human Health. Environ Toxicol Pharmacol. 2015;40:241-58.
    [CrossRef] [PubMed] [Google Scholar]
  22. , . DDT, Epigenetic Harm, and Transgenerational Environmental Justice. Environ Health. 2014;13:62.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , . Phthalate Exposure and Long-Term Epigenomic Consequences: A Review. Front Genet. 2020;11:405.
    [CrossRef] [PubMed] [Google Scholar]
  24. , . Epigenetic Effects of Environmental Chemicals Bisphenol A and Phthalates. Int J Mol Sci. 2012;13:10143-53.
    [CrossRef] [PubMed] [Google Scholar]
  25. . Environmental Contaminants, Endocrine Disruption, and Transgender: 'Can Born That Way' in Some Cases Be Toxicologically Real? Hum Exp Toxicol. 2023;42:1-11.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , . Effects of Developmental Exposure to Bisphenol A on Brain and Behavior in Mice. Environ Res. 2008;108:150-7.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , . Risk Evaluation of Endocrine-Disrupting Chemicals: Effects of Developmental Exposure to Low Doses of Bisphenol A on Behavior and Physiology in Mice (Mus musculus) Dose Response. 2015;13:1559325815610760.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , , . Transgenerational Effects of Di-(2-Ethylhexyl) Phthalate (DEHP) on Stress Hormones and Behavior. Endocrinology. 2015;156:3077-83.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , , . Direct and Transgenerational Effects of Low Doses of Perinatal Di-(2-Ethylhexyl) Phthalate (DEHP) on Social Behaviors in Mice. PLoS One. 2017;12:e0171977.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , , , . Transgenerational Effects of Bisphenol A on Gene Expression and DNA Methylation of Imprinted Genes in Brain. Endocrinology. 2018;159:132-44.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , , , . Exposure to Di-(2-Ethylhexyl) Phthalate Transgenerationally Alters Anxiety-Like Behavior and Amygdala Gene Expression in Adult Male and Female Mice. Physiol Behav. 2019;207:7-14.
    [CrossRef] [PubMed] [Google Scholar]
  32. , . A Sex Difference in the Hypothalamic Uncinate Nucleus: Relationship to Gender Identity. Brain. 2008;131:3132-46.
    [CrossRef] [PubMed] [Google Scholar]
  33. , , , . A Sex Difference in the Human Brain and Its Relation to Transsexuality. Nature. 1995;378:68-70.
    [CrossRef] [PubMed] [Google Scholar]
  34. , , , , , . Male-to-Female Transsexuals Have Female Neuron Numbers in a Limbic Nucleus. J Clin Endocrinol Metab. 2000;85:2034-41.
    [CrossRef] [PubMed] [Google Scholar]
  35. , , , , , . Kisspeptin Expression in the Human Infundibular Nucleus in Relation to Sex, Gender Identity, and Sexual Orientation. J Clin Endocrinol Metab. 2016;101:2380-9.
    [CrossRef] [PubMed] [Google Scholar]
  36. , , , , , , et al. Brain Functional Connectivity Patterns in Children and Adolescents With Gender Dysphoria: Sex-Atypical or Not? Psychoneuroendocrinology. 2017;86:187-95.
    [CrossRef] [PubMed] [Google Scholar]
  37. . Family Cooccurrence of “Gender Dysphoria”: Ten Sibling or Parent-Child Pairs. Arch Sex Behav. 2000;29:499-507.
    [CrossRef] [PubMed] [Google Scholar]
  38. , , , , , . Familiality of Gender Identity Disorder in Non-Twin Siblings. Arch Sex Behav. 2010;39:546-52.
    [CrossRef] [PubMed] [Google Scholar]
  39. , , . Genetic and Environmental Influences on Cross-Gender Behavior and Relation to Behavior Problems: A Study of Dutch Twins at Ages 7 and 10 Years. Arch Sex Behav. 2006;35:647-58.
    [CrossRef] [PubMed] [Google Scholar]
  40. , , , , , , et al. Gender Identity Disorder in Twins: A Review of the Case Report Literature. J Sex Med. 2012;9:751-7.
    [CrossRef] [PubMed] [Google Scholar]
  41. , , , , , , et al. Karyotyping, Is It Worthwhile in Transsexualism? J Sex Med. 2011;8:475-8.
    [CrossRef] [PubMed] [Google Scholar]
  42. , , , . Molecular Karyotyping in Children and Adolescents With Gender Dysphoria. Transgend Health. 2018;3:147-53.
    [CrossRef] [PubMed] [Google Scholar]
  43. , , , , , , et al. Analyses of Karyotype by G-Banding and High-Resolution Microarrays in a Gender Dysphoria Population. Genes Genom. 2018;40:465-73.
    [CrossRef] [PubMed] [Google Scholar]
  44. , , , . Assessment and Support of Children and Adolescents With Gender Dysphoria. Arch Dis Child. 2018;103:631-6.
    [CrossRef] [PubMed] [Google Scholar]
  45. , , , , , . New Studies of Second and Fourth Digit Ratio as a Morphogenetic Trait in Subjects With Congenital Adrenal Hyperplasia. Am J Hum Biol. 2014;26:559-61.
    [CrossRef] [PubMed] [Google Scholar]
  46. , , , . 2D:4D Finger-Length Ratios in Children and Adults With Gender Identity Disorder. Horm Behav. 2008;54:450-4.
    [CrossRef] [PubMed] [Google Scholar]
  47. , , , , , . Finger Length Ratio (2D:4D) in Adults With Gender Identity Disorder. Arch Sex Behav. 2009;38:359-36.
    [CrossRef] [PubMed] [Google Scholar]
  48. . Gender Identity Disorder In: , , , eds. Handbook of Developmental Psychopathology (2nd ed). New York, NY: Kluwer Academic/Plenum; . p. :671-86.
    [CrossRef] [Google Scholar]
  49. . A Cognitive-Developmental Analysis of Children's Sex-Role Concepts and Attitudes In: , ed. The Development of Sex Differences. Stanford, CA: Stanford University Press; . p. :82-173.
    [Google Scholar]
  50. , , , , , , et al. Gender Constancy Judgments in Children With Gender Identity Disorder: Evidence for a Developmental Lag. Arch Sex Behav. 1999;28:475-502.
    [CrossRef] [PubMed] [Google Scholar]
  51. , . Extreme Boyhood Femininity: Isolated Behavior or Pervasive Disorder? J Am Acad Child Psychiatry. 1985;24:702-9.
    [CrossRef] [PubMed] [Google Scholar]
  52. , , , , . Autism Spectrum Disorders in Gender Dysphoric Children and Adolescents. J Autism Dev Disord. 2010;40:930-6.
    [CrossRef] [PubMed] [Google Scholar]
  53. , , , . A Developmental, Biopsychosocial Model for the Treatment of Children With Gender Identity Disorder. J Homosex. 2012;59:369-97.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections